Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
LKB1 when associated with methylatedERα is a marker of bad prognosis in breast cancer.
Bouchekioua-Bouzaghou K, Poulard C, Rambaud J, Lavergne E, Hussein N, Billaud M, Bachelot T, Chabaud S, Mader S, Dayan G, Treilleux I, Corbo L, Le Romancer M. Bouchekioua-Bouzaghou K, et al. Among authors: bachelot t. Int J Cancer. 2014 Sep 15;135(6):1307-18. doi: 10.1002/ijc.28781. Epub 2014 Mar 4. Int J Cancer. 2014. PMID: 24615515
Breast carcinoma cells promote the differentiation of CD34+ progenitors towards 2 different subpopulations of dendritic cells with CD1a(high)CD86(-)Langerin- and CD1a(+)CD86(+)Langerin+ phenotypes.
Thomachot MC, Bendriss-Vermare N, Massacrier C, Biota C, Treilleux I, Goddard S, Caux C, Bachelot T, Blay JY, Menetrier-Caux C. Thomachot MC, et al. Among authors: bachelot t. Int J Cancer. 2004 Jul 10;110(5):710-20. doi: 10.1002/ijc.20146. Int J Cancer. 2004. PMID: 15146561
Dendritic cell infiltration and prognosis of early stage breast cancer.
Treilleux I, Blay JY, Bendriss-Vermare N, Ray-Coquard I, Bachelot T, Guastalla JP, Bremond A, Goddard S, Pin JJ, Barthelemy-Dubois C, Lebecque S. Treilleux I, et al. Among authors: bachelot t. Clin Cancer Res. 2004 Nov 15;10(22):7466-74. doi: 10.1158/1078-0432.CCR-04-0684. Clin Cancer Res. 2004. PMID: 15569976
[Neoadjuvant chemotherapy and ovarian cancer].
Ray-Coquard I, Saba C, Bachelot T, Méeus P, Mignotte H, Blondet R, Treilleux I, Peix M, Guastalla JP. Ray-Coquard I, et al. Among authors: bachelot t. Bull Cancer. 2006 Jul;93(7):669-76. Bull Cancer. 2006. PMID: 16873075 Free article. Review. French.
A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study.
Cassier PA, Chabaud S, Trillet-Lenoir V, Peaud PY, Tigaud JD, Cure H, Orfeuvre H, Salles B, Martin C, Jacquin JP, Agostini C, Guastalla JP, Pérol D, Bachelot T. Cassier PA, et al. Among authors: bachelot t. Breast Cancer Res Treat. 2008 May;109(2):343-50. doi: 10.1007/s10549-007-9651-3. Epub 2007 Jul 5. Breast Cancer Res Treat. 2008. PMID: 17611792 Clinical Trial.
Development of a rule based prognostic tool for HER 2 positive breast cancer patients.
Lisboa PJ, Etchells TA, Jarman IH, Aung MS, Chabaud S, Bachelot T, Perol D, Gargi T, Bourdès V, Bonnevay S, Négrier S. Lisboa PJ, et al. Among authors: bachelot t. Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:5416-9. doi: 10.1109/IEMBS.2007.4353567. Annu Int Conf IEEE Eng Med Biol Soc. 2007. PMID: 18003233
330 results